SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-005381
Filing Date
2022-04-05
Accepted
2022-04-05 20:26:27
Documents
12
Period of Report
2022-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K srpt-20220331.htm   iXBRL 8-K 49850
  Complete submission text file 0000950170-22-005381.txt   163174

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srpt-20220331.xsd EX-101.SCH 2520
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srpt-20220331_lab.xml EX-101.LAB 12798
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srpt-20220331_pre.xml EX-101.PRE 9475
6 EXTRACTED XBRL INSTANCE DOCUMENT srpt-20220331_htm.xml XML 4527
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 22809095
SIC: 2834 Pharmaceutical Preparations